Cargando…

In Vivo Measurement of Hippocampal GABA(A)/cBZR Density with [(18)F]-Flumazenil PET for the Study of Disease Progression in an Animal Model of Temporal Lobe Epilepsy

PURPOSE: Imbalance of inhibitory GABAergic neurotransmission has been proposed to play a role in the pathogenesis of temporal lobe epilepsy (TLE). This study aimed to investigate whether [(18)F]-flumazenil ([(18)F]-FMZ) PET could be used to non-invasively characterise GABA(A)/central benzodiazepine...

Descripción completa

Detalles Bibliográficos
Autores principales: Vivash, Lucy, Gregoire, Marie-Claude, Bouilleret, Viviane, Berard, Alexis, Wimberley, Catriona, Binns, David, Roselt, Peter, Katsifis, Andrew, Myers, Damian E., Hicks, Rodney J., O'Brien, Terence J., Dedeurwaerdere, Stefanie
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2014
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3897736/
https://www.ncbi.nlm.nih.gov/pubmed/24466212
http://dx.doi.org/10.1371/journal.pone.0086722
_version_ 1782300293591990272
author Vivash, Lucy
Gregoire, Marie-Claude
Bouilleret, Viviane
Berard, Alexis
Wimberley, Catriona
Binns, David
Roselt, Peter
Katsifis, Andrew
Myers, Damian E.
Hicks, Rodney J.
O'Brien, Terence J.
Dedeurwaerdere, Stefanie
author_facet Vivash, Lucy
Gregoire, Marie-Claude
Bouilleret, Viviane
Berard, Alexis
Wimberley, Catriona
Binns, David
Roselt, Peter
Katsifis, Andrew
Myers, Damian E.
Hicks, Rodney J.
O'Brien, Terence J.
Dedeurwaerdere, Stefanie
author_sort Vivash, Lucy
collection PubMed
description PURPOSE: Imbalance of inhibitory GABAergic neurotransmission has been proposed to play a role in the pathogenesis of temporal lobe epilepsy (TLE). This study aimed to investigate whether [(18)F]-flumazenil ([(18)F]-FMZ) PET could be used to non-invasively characterise GABA(A)/central benzodiazepine receptor (GABA(A)/cBZR) density and affinity in vivo in the post-kainic acid status epilepticus (SE) model of TLE. METHODS: Dynamic [(18)F]-FMZ -PET scans using a multi-injection protocol were acquired in four male wistar rats for validation of the partial saturation model (PSM). SE was induced in eight male Wistar rats (10 weeks of age) by i.p. injection of kainic acid (7.5–25 mg/kg), while control rats (n = 7) received saline injections. Five weeks post-SE, an anatomic MRI scan was acquired and the following week an [(18)F]-FMZ PET scan (3.6–4.6 nmol). The PET data was co-registered to the MRI and regions of interest drawn on the MRI for selected structures. A PSM was used to derive receptor density and apparent affinity from the [(18)F]-FMZ PET data. KEY FINDINGS: The PSM was found to adequately model [(18)F]-FMZ binding in vivo. There was a significant decrease in hippocampal receptor density in the SE group (p<0.01), accompanied by an increase in apparent affinity (p<0.05) compared to controls. No change in cortical receptor binding was observed. Hippocampal volume reduction and cell loss was only seen in a subset of animals. Histological assessment of hippocampal cell loss was significantly correlated with hippocampal volume measured by MRI (p<0.05), but did not correlate with [(18)F]-FMZ binding. SIGNIFICANCE: Alterations to hippocampal GABA(A)/cBZR density and affinity in the post-kainic acid SE model of TLE are detectable in vivo with [(18)F]-FMZ PET and a PSM. These changes are independent from hippocampal cell and volume loss. [(18)F]-FMZ PET is useful for investigating the role that changes GABA(A)/cBZR density and binding affinity play in the pathogenesis of TLE.
format Online
Article
Text
id pubmed-3897736
institution National Center for Biotechnology Information
language English
publishDate 2014
publisher Public Library of Science
record_format MEDLINE/PubMed
spelling pubmed-38977362014-01-24 In Vivo Measurement of Hippocampal GABA(A)/cBZR Density with [(18)F]-Flumazenil PET for the Study of Disease Progression in an Animal Model of Temporal Lobe Epilepsy Vivash, Lucy Gregoire, Marie-Claude Bouilleret, Viviane Berard, Alexis Wimberley, Catriona Binns, David Roselt, Peter Katsifis, Andrew Myers, Damian E. Hicks, Rodney J. O'Brien, Terence J. Dedeurwaerdere, Stefanie PLoS One Research Article PURPOSE: Imbalance of inhibitory GABAergic neurotransmission has been proposed to play a role in the pathogenesis of temporal lobe epilepsy (TLE). This study aimed to investigate whether [(18)F]-flumazenil ([(18)F]-FMZ) PET could be used to non-invasively characterise GABA(A)/central benzodiazepine receptor (GABA(A)/cBZR) density and affinity in vivo in the post-kainic acid status epilepticus (SE) model of TLE. METHODS: Dynamic [(18)F]-FMZ -PET scans using a multi-injection protocol were acquired in four male wistar rats for validation of the partial saturation model (PSM). SE was induced in eight male Wistar rats (10 weeks of age) by i.p. injection of kainic acid (7.5–25 mg/kg), while control rats (n = 7) received saline injections. Five weeks post-SE, an anatomic MRI scan was acquired and the following week an [(18)F]-FMZ PET scan (3.6–4.6 nmol). The PET data was co-registered to the MRI and regions of interest drawn on the MRI for selected structures. A PSM was used to derive receptor density and apparent affinity from the [(18)F]-FMZ PET data. KEY FINDINGS: The PSM was found to adequately model [(18)F]-FMZ binding in vivo. There was a significant decrease in hippocampal receptor density in the SE group (p<0.01), accompanied by an increase in apparent affinity (p<0.05) compared to controls. No change in cortical receptor binding was observed. Hippocampal volume reduction and cell loss was only seen in a subset of animals. Histological assessment of hippocampal cell loss was significantly correlated with hippocampal volume measured by MRI (p<0.05), but did not correlate with [(18)F]-FMZ binding. SIGNIFICANCE: Alterations to hippocampal GABA(A)/cBZR density and affinity in the post-kainic acid SE model of TLE are detectable in vivo with [(18)F]-FMZ PET and a PSM. These changes are independent from hippocampal cell and volume loss. [(18)F]-FMZ PET is useful for investigating the role that changes GABA(A)/cBZR density and binding affinity play in the pathogenesis of TLE. Public Library of Science 2014-01-21 /pmc/articles/PMC3897736/ /pubmed/24466212 http://dx.doi.org/10.1371/journal.pone.0086722 Text en © 2014 Vivash et al http://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are properly credited.
spellingShingle Research Article
Vivash, Lucy
Gregoire, Marie-Claude
Bouilleret, Viviane
Berard, Alexis
Wimberley, Catriona
Binns, David
Roselt, Peter
Katsifis, Andrew
Myers, Damian E.
Hicks, Rodney J.
O'Brien, Terence J.
Dedeurwaerdere, Stefanie
In Vivo Measurement of Hippocampal GABA(A)/cBZR Density with [(18)F]-Flumazenil PET for the Study of Disease Progression in an Animal Model of Temporal Lobe Epilepsy
title In Vivo Measurement of Hippocampal GABA(A)/cBZR Density with [(18)F]-Flumazenil PET for the Study of Disease Progression in an Animal Model of Temporal Lobe Epilepsy
title_full In Vivo Measurement of Hippocampal GABA(A)/cBZR Density with [(18)F]-Flumazenil PET for the Study of Disease Progression in an Animal Model of Temporal Lobe Epilepsy
title_fullStr In Vivo Measurement of Hippocampal GABA(A)/cBZR Density with [(18)F]-Flumazenil PET for the Study of Disease Progression in an Animal Model of Temporal Lobe Epilepsy
title_full_unstemmed In Vivo Measurement of Hippocampal GABA(A)/cBZR Density with [(18)F]-Flumazenil PET for the Study of Disease Progression in an Animal Model of Temporal Lobe Epilepsy
title_short In Vivo Measurement of Hippocampal GABA(A)/cBZR Density with [(18)F]-Flumazenil PET for the Study of Disease Progression in an Animal Model of Temporal Lobe Epilepsy
title_sort in vivo measurement of hippocampal gaba(a)/cbzr density with [(18)f]-flumazenil pet for the study of disease progression in an animal model of temporal lobe epilepsy
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3897736/
https://www.ncbi.nlm.nih.gov/pubmed/24466212
http://dx.doi.org/10.1371/journal.pone.0086722
work_keys_str_mv AT vivashlucy invivomeasurementofhippocampalgabaacbzrdensitywith18fflumazenilpetforthestudyofdiseaseprogressioninananimalmodeloftemporallobeepilepsy
AT gregoiremarieclaude invivomeasurementofhippocampalgabaacbzrdensitywith18fflumazenilpetforthestudyofdiseaseprogressioninananimalmodeloftemporallobeepilepsy
AT bouilleretviviane invivomeasurementofhippocampalgabaacbzrdensitywith18fflumazenilpetforthestudyofdiseaseprogressioninananimalmodeloftemporallobeepilepsy
AT berardalexis invivomeasurementofhippocampalgabaacbzrdensitywith18fflumazenilpetforthestudyofdiseaseprogressioninananimalmodeloftemporallobeepilepsy
AT wimberleycatriona invivomeasurementofhippocampalgabaacbzrdensitywith18fflumazenilpetforthestudyofdiseaseprogressioninananimalmodeloftemporallobeepilepsy
AT binnsdavid invivomeasurementofhippocampalgabaacbzrdensitywith18fflumazenilpetforthestudyofdiseaseprogressioninananimalmodeloftemporallobeepilepsy
AT roseltpeter invivomeasurementofhippocampalgabaacbzrdensitywith18fflumazenilpetforthestudyofdiseaseprogressioninananimalmodeloftemporallobeepilepsy
AT katsifisandrew invivomeasurementofhippocampalgabaacbzrdensitywith18fflumazenilpetforthestudyofdiseaseprogressioninananimalmodeloftemporallobeepilepsy
AT myersdamiane invivomeasurementofhippocampalgabaacbzrdensitywith18fflumazenilpetforthestudyofdiseaseprogressioninananimalmodeloftemporallobeepilepsy
AT hicksrodneyj invivomeasurementofhippocampalgabaacbzrdensitywith18fflumazenilpetforthestudyofdiseaseprogressioninananimalmodeloftemporallobeepilepsy
AT obrienterencej invivomeasurementofhippocampalgabaacbzrdensitywith18fflumazenilpetforthestudyofdiseaseprogressioninananimalmodeloftemporallobeepilepsy
AT dedeurwaerderestefanie invivomeasurementofhippocampalgabaacbzrdensitywith18fflumazenilpetforthestudyofdiseaseprogressioninananimalmodeloftemporallobeepilepsy